Rising Chronic Disease Burden, Biosimilar Insulin Adoption, and Smart Connected Pen Technologies Drive Sustained Market Expansion.Austin, United States, March 12, 2026 (GLOBE NEWSWIRE) -- As per SNS ...

Mysuru: Parents of children undergoing treatment for Type 1 diabetes have welcomed the Karnataka govt's decision to provide ...

Diabetes hardware company embecta aims to look beyond insulin and reshape itself into a more varied drug delivery provider—and it’s kick-starting that effort with the acquisition of a glo | Embecta ...

On the heels of its debut as a public company, Medtronic’s former diabetes division MiniMed has claimed a European approval to connect its mainstay insulin pump with an exclusive continuous glucose ...

Ozempic is a popular injectable medication that has gained attention worldwide, especially for managing type 2 diabetes and aiding weight loss. Its active ingredient, semaglutide, belongs to a class ...

Alkem Laboratories is all set to launch a semaglutide injection under the brand names Semasize, Obesema and Hepaglide priced ...

Insulin therapy is central to type 1 diabetes and many cases of type 2. It lowers glucose effectively, yet it also introduces predictable risks. Understanding side effects helps patients plan […] ...

Natco Pharma has launched a generic semaglutide injection for diabetes treatment in India, significantly undercutting existing market prices.

ILLEGAL fake weight loss jabs are now being sold in pubs and fish and chip shops, a concerning report has revealed. The ...

Torrent Pharma launched its Semaglutide brands, Sembolic and Semalix, in both oral and injectable formulations ...

MOUNJARO pens will be shrunk from April to try and stop patients squeezing out a “golden” fifth dose after the four prescribed shots. Users of the weight loss jab have for months been injecting ...

Semaglutide's patent expiry in India could sharply reduce the cost of popular weight-loss and diabetes injections.